Enrolling Clinical Studies
MEMORY LOSS / MILD ALZHEIMER'S STUDY
This study will evaluate the safety, tolerability and immunogenicity of a subcutaneous injection as a treatment in patients with mild Alzheimer’s disease.
Requirements:
• Male or female between the ages of 55 and 85 years.
• Have a BMI index between 18-32 Kg/m
• Subjects with confirmed or suspected diagnosis of mild Alzheimer’s or cognitive impairment.
• Subjects willing and able to complete brain imaging (MRI and PET Scans)
• No history of autoimmune disorders, severe food allergy, hypersensitivity to antibodies.
• No history of angina, pacemaker, myocardial infarction or chronic heart failure in the past year.
• No history of HIV, Hepatitis B or C.
• No subjects with Type 1 diabetes or uncontrolled type 2 diabetes.
• No subjects with other psychiatric condition: schizophrenia, major depression or bipolar.
• No subjects receiving anti-coagulation medications within 3 months of screening.
Study Duration:
This study consists in 9 visits in term of 4 month.This study contains a total of 19 office visits, around 2 MRIs and 2 PET Scans,
over a period of 24 weeks.
Compensation:
Financial compensation for time & transportation may be provided